P. Marks

522 total citations
17 papers, 316 citations indexed

About

P. Marks is a scholar working on Hepatology, Epidemiology and Pharmacology. According to data from OpenAlex, P. Marks has authored 17 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hepatology, 5 papers in Epidemiology and 4 papers in Pharmacology. Recurrent topics in P. Marks's work include Hepatitis C virus research (6 papers), Hepatitis B Virus Studies (4 papers) and Drug-Induced Adverse Reactions (2 papers). P. Marks is often cited by papers focused on Hepatitis C virus research (6 papers), Hepatitis B Virus Studies (4 papers) and Drug-Induced Adverse Reactions (2 papers). P. Marks collaborates with scholars based in United Kingdom, Australia and Malaysia. P. Marks's co-authors include Barbara Yeung, Gail Matthews, Andrew R. Lloyd, William D. Rawlinson, Margaret Hellard, John Kaldor, David Booth, Jason Grebely, Gregory J. Dore and Jacob George and has published in prestigious journals such as Hepatology, Clinical Infectious Diseases and Journal of Hepatology.

In The Last Decade

P. Marks

17 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P. Marks United Kingdom	7	223	195	60	55	19	17	316
Arturo Pérez‐Mota Spain	5	271 1.2×	242 1.2×	17 0.3×	36 0.7×	6 0.3×	7	352
Estela Álvarez Argentina	9	333 1.5×	379 1.9×	20 0.3×	31 0.6×	14 0.7×	17	446
Željko Mijailović Serbia	11	57 0.3×	69 0.4×	88 1.5×	13 0.2×	8 0.4×	44	270
C. Cancellieri Italy	5	240 1.1×	254 1.3×	23 0.4×	7 0.1×	45 2.4×	12	339
Antonio Carlotto Italy	7	265 1.2×	324 1.7×	65 1.1×	15 0.3×	6 0.3×	13	360
Miriam Cuarterolo Argentina	13	466 2.1×	364 1.9×	61 1.0×	70 1.3×	8 0.4×	28	557
Alistair McNair United Kingdom	6	182 0.8×	171 0.9×	18 0.3×	17 0.3×	19 1.0×	10	262
Mario Magnone United States	6	156 0.7×	236 1.2×	85 1.4×	12 0.2×	4 0.2×	14	364
Susana López Argentina	9	206 0.9×	166 0.9×	23 0.4×	21 0.4×	4 0.2×	15	293
Albert Knapp United States	8	19 0.1×	67 0.3×	19 0.3×	18 0.3×	11 0.6×	17	250

Countries citing papers authored by P. Marks

Since Specialization

Citations

This map shows the geographic impact of P. Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Marks more than expected).

Fields of papers citing papers by P. Marks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Marks. The network helps show where P. Marks may publish in the future.

Co-authorship network of co-authors of P. Marks

This figure shows the co-authorship network connecting the top 25 collaborators of P. Marks. A scholar is included among the top collaborators of P. Marks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Marks. P. Marks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Hajarizadeh, Behzad, Jason Grebely, Marianne Byrne, et al.. (2018). Incidence of hepatitis C virus infection in four prisons in New South Wales, Australia: The SToP-C study. Journal of Hepatology. 68. S187–S188. 2 indexed citations

Lamoury, F., Behzad Hajarizadeh, D. Martínez, et al.. (2017). Hepatitis C virus core antigen and dried blood spots as simplified hepatitis C virus diagnostic tools. Journal of Hepatology. 66(1). S710–S710. 1 indexed citations

Hajarizadeh, Behzad, Jason Grebely, Marianne Byrne, et al.. (2017). Incidence of hepatitis C virus infection in two maximum-security prisons in New South Wales, Australia: the SToP-C study. Journal of Hepatology. 66(1). S274–S274. 3 indexed citations

Grebely, Jason, Kathy Petoumenos, Margaret Hellard, et al.. (2010). Potential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus Infection. Hepatology. 52(4). 1216–1224. 138 indexed citations

Matthews, Gail, Jason Grebely, Margaret Hellard, et al.. (2010). 276 WEEK 4 HCV RNA IS THE OPTIMAL PREDICTOR OF SVR IN BOTH HIV POSITIVE AND NEGATIVE SUBJECTS WITHIN THE AUSTRALIAN TRIAL IN ACUTE HCV. Journal of Hepatology. 52. S116–S116. 1 indexed citations

Matthews, Gail, Margaret Hellard, Paul Haber, et al.. (2009). Characteristics and Treatment Outcomes among HIV‐Infected Individuals in the Australian Trial in Acute Hepatitis C. Clinical Infectious Diseases. 48(5). 650–658. 84 indexed citations

Marks, P., et al.. (1998). Degradation of benzene by a Rhodococcus sp. using immobilized cell systems. World Journal of Microbiology and Biotechnology. 14(5). 675–680. 13 indexed citations

Manna, Vasant K., P. Marks, & John R. Gibson. (1992). An Evaluation of the Antihistamine Activity of Acrivastine and Its Onset in Human Skin. Journal of International Medical Research. 20(2). 106–111. 5 indexed citations

Pettit, John H. S., et al.. (1991). Trimethoprim‐Polymyxin B Sulfate Cream Versus Fusidic Acid Cream in the Treatment of Pyodermas: An Update. International Journal of Dermatology. 30(10). 746–746. 1 indexed citations

10.

Harvey, Susan, et al.. (1990). Trimethoprim – Polymyxin B Sulphate Cream Compared with Fusidic Acid Cream in the Treatment of Superficial Bacterial Infection of the Skin. Journal of International Medical Research. 18(2). 89–93. 5 indexed citations

11.

Kay, Elizabeth, et al.. (1989). Acute gastric stress ulceration: prophylaxis with allopurinol.. PubMed. 34(6). 321–5. 2 indexed citations

12.

Marks, P., et al.. (1989). Acrivastine--an evaluation of initial and peak activity in human skin.. PubMed. 17 Suppl 2. 3B–8B. 11 indexed citations

13.

Pettit, John H. S., et al.. (1987). Trimethoprim‐Polymyxin B Sulfate Cream versus Fusidic Acid Cream in the Treatment of Pyodermas. International Journal of Dermatology. 26(1). 60–63. 4 indexed citations

14.

Gibson, John R., Susan Harvey, D. Kemmett, J R Salisbury, & P. Marks. (1986). Treatment of common and plantar viral warts with human lymphoblastoid interferon-α—pilot studies with intralesional, intramuscular and dermojet injections. British Journal of Dermatology. 115(s31). 76–79. 22 indexed citations

15.

Marks, P., et al.. (1979). Epileptiform seizures with maprotiline hydrochloride. Postgraduate Medical Journal. 55(648). 742–742. 7 indexed citations

16.

Marks, P., et al.. (1978). Drug dependence caused by dihydrocodeine.. BMJ. 1(6127). 1594–1594. 16 indexed citations

17.

Marks, P.. (1974). Methaqualone and peripheral neuropathy.. PubMed. 212(1271). 721–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact